Drug · DIN 02457482
ADENOSINE INJECTION
12 MG/4 ML SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 17, 2017; first marketed August 17, 2017.
- Drug Identification Number (DIN)
- 02457482
- Company (DIN owner)
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Adenosine C01EB10
- Class
- Human
- Record last updated
- August 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADENOSINE | 3 MG | ML |
Other DINs named ADENOSINE INJECTION
- DIN 02267659 · Marketed
- DIN 02457474 · Marketed